The short version
7 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Adenosine
Adenosine · ADENOSINE 3 mg/mL · Injection, Solution · Intravenous · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC 23155-0258-31 · 1 VIAL in 1 CARTON / 20 mL in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$65.00
Reported to Texas DSHS · 2026 annual filing · Heritage Pharmaceuticals, Inc. d/b/a Avet Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$1,336
29 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · label · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA202313
- TE code
- AP
- Approval date
- Sep 15, 2014
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Adenosine (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Kabi USA, LLC | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| HF Acquisition Co LLC, DBA HealthFirst | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Meitheal Pharmaceuticals Inc. | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Eugia US LLC | ADENOSINE 60 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | ADENOSINE 90 mg/30mL | Jul 15, 2026 | Sep 2, 2026 |
| Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ADENOSINE 3 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | ADENOSINE 3 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| NorthStar Rx LLC | ADENOSINE 3 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Adenosine — NDC 23155-0258-31," retrieved September 3, 2026, https://drugdashboards.com/drug/23155025831.
Free to cite with attribution — see how the data is put together.